PCYN · Procyon Corp
Market Cap
$2.03M
Shares
8.12M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.25
Open$0.25
Day$0.25–0.25
Available close range$0.11–0.28
Avg vol 30d8K
Short int160 · 0.0% float · 1.0d
Short vol100%
DataJan 2020–Aug 2026
Filing10-K · Oct 25
The closing range uses available history since Sep 23, 2025; less than a full year is stored.
Up next
filed Oct 25, 2024
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$4.98M
Trailing 12 months
Net income (TTM)
−$341,140
Trailing 12 months
Revenue growth YoY
+17.5%
Year over year
Operating margin
-4.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-6.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.3%
Year over year · more shares
Price change (1Y)
+145.1%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−10%
below
Price vs 50-day avg
+25%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
82%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+107%
trailing
6-month return
+4%
trailing
YTD return
+107%
this year
Relative strength
−8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
+6%
Y/Y
Gross margin
78%
expanding
EPS growth
−300%
Y/Y
Free cash flow
$-125.2K
Quant / Vol
risk profile
Volatility
14546%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
12.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−10%
Bearish
Price vs 50-day avg
+25%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
82%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $0
Now $0 · 82%
Range high $0
vs 200-day avg -10%
vs 50-day avg +25%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PCYN
this stock
Procyon Corp
|
$2.03M | — | +6.4% | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.66B | +18.2% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$47.50B | -1.7% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$43.03B | +20.1% | +4.3% | 60.5 | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PCYN | -10.7% | +106.6% | +4.2% | -10.7% | +106.6% |
| SPY | -0.4% | +5.0% | +12.4% | +2.6% | +12.3% |
| vs SPY | -10.3% | +101.6% | -8.3% | -13.3% | +94.3% |